Moreover, the silencing of HIGD2A alters the viability of DLD1 colon adenocarcinoma cells, indicating that silencing HIGD2A induces death in cancer cells, suggesting a role for HIG2A in cell cycle regulation and a potential target in cancer therapy [16]. This evidence concerns the gene HIGD2A and colon adenocarcinoma.